Home > Balance Sheet > NEULAND LABORATORIES

NEULAND LABORATORIES
Contingent Liabilities

    Back to Balance Sheet
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹8.97 Cr₹28 Cr₹91 Cr₹75 Cr₹105 Cr

What is the latest Contingent Liabilities ratio of NEULAND LABORATORIES ?

The latest Contingent Liabilities ratio of NEULAND LABORATORIES is ₹8.97 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹8.97 Cr
Mar2024₹28 Cr
Mar2023₹91 Cr
Mar2022₹75 Cr
Mar2021₹105 Cr

How is Contingent Liabilities of NEULAND LABORATORIES Trending?

Years Contingent Liabilities % Change
Mar2025 ₹8.97 Cr
-67.65
Mar2024 ₹28 Cr
-69.60
Mar2023 ₹91 Cr
22.14
Mar2022 ₹75 Cr
-28.68
Mar2021 ₹105 Cr -

Compare Contingent Liabilities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹15,548.8 Cr -3.7% -7.8% 4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-3.7%

-7.8%

4%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses